Figure 1.
Mean plasma concentration–time profiles in subjects with varying degrees of renal function after either intravenous infusion of 300 mg of delafloxacin (A) or oral administration of 400 mg of delafloxacin (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.